# Analysis of Circulating Tumor Markers in Blood - ALCINA 5

> **NCT07060950** · NA · NOT_YET_RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 620 (estimated)

## Conditions studied

- Cancer
- Lung Cancer, Non-Small Cell

## Interventions

- **BIOLOGICAL:** Blood sampling C1

## Key facts

- **NCT ID:** NCT07060950
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2030-07
- **Final completion:** 2035-07
- **Target enrollment:** 620 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060950, "Analysis of Circulating Tumor Markers in Blood - ALCINA 5". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07060950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*